RJ Hamster
Trump Lays Down The Law – ‘I Will Not Do It’ | Republic News Team
— Read on republicnewsteam.com/winner/trump-lays-down-the-law-i-will-not-do-it-2/
RJ Hamster
Updates on the tragic Canadian school shooting in Tumbler Ridge, BC, with details about the shooter and victims.
— Read on townhall.com/tipsheet/mattvespa/2026/02/11/canadian-school-shooter-identified-n2671103
RJ Hamster
Peter, you’ve met our legislative priorities for 2026. From Early Childhood funding and childcare subsidies to justice reform and supporting teachers in the classroom, we’re all in this legislative session.
Can you take the next step with us?
Join us for our virtual February RTS training on February 26th at 6PM to gain the tools and knowledge to share your voice with lawmakers without ever leaving your home.
RTS is one of the most powerful tools we have to influence what happens at the Capitol.
Weigh directly in support of bills like HB 2265 to eliminate constitutional fees from the adult court system or HB 4032 to close the Vape Tax Loophole and generate $80 million dollars to invest in early childhood programs.
Whether you’re brand new to RTS or just want a quick refresher, we’ll walk you through everything step by step, so you feel confident and ready to take action. We’ll even set up and activate your account for you!
Let’s secure some big wins for our communities this year.
Standing with You
Sarah Jedlowski, Digital Organizing Manager
Stand for Children Arizona
Stand for Children Arizona is a unique catalyst for educational success and social progress, to create a brighter future for us all.
If you believe you received this message in error or wish to no longer receive email from us, please unsubscribe.
RJ Hamster
If you have a strong eye prescription, high-index lenses may be right for you. Learn what high-index lenses are and how they compare to other lens options.
— Read on www.warbyparker.com/learn/what-are-high-index-lenses
RJ Hamster
Dear Reader,
One of the market’s greatest “sleeper stocks” may be about to wake up.
And Wall Street has begun to take notice.
The ticker shot up 5% in a single week as analysts recently raised its price target – and elevated the stock from a “Hold” to a “BUY.”
In fact, one 50-year Wall Street legend just named it his #1 stock of 2026 – live, on-camera.
When you see the role this company is playing in a $269 billion market, you’ll understand why he’s telling his 800,000 followers to put $1,000 into the stock NOW.
(And why BlackRock even made a multi-billion-dollar offer to buy the company behind it.)
Right now, institutional investors hold over 50% of the stock.
But the tide may soon be about to change, as more and more retail investors catch onto its extraordinary potential.
The best part?
As of this writing, it’s trading just around $15 a share.
That’s one-twelfth the price of Nvidia (NVDA).
So if you missed out on NVDA’s extraordinary runup…
This is your rare second chance to get in NOW, before this undervalued stock could become one of the best-performing stocks of the new year.
Click here to get the name and ticker, 100% free.
Regards,
Kelly Brown
Host, Chaikin Analytics
More Reading from MarketBeat
By Jordan Chussler. Published: 1/31/2026.
One year ago, President Donald Trump was being hailed as the United States’ first crypto president. His deregulatory platform was expected to be a boon for stocks in the financials sector as well as the crypto industry.
But things did not go quite as planned. In 2025, financials ranked second-to-last among the S&P 500’s 11 sectors, returning just over 5%. Crypto investors were even more disappointed.
For the first time ever, James Altucher – one of America’s top venture capitalists – is sharing how ANYONE can get a pre-IPO stake in SpaceX… with as little as $100![[Click here now to view.]]
After hitting a then-all-time high on Jan. 25 (five days after Trump took office for the start of his second term), Bitcoin (BTC) has fallen nearly 15% from that level and more than 27% from its current record high on Oct. 4, 2025.
That pain wasn’t limited to decentralized finance. With the rise of crypto spot exchange-traded funds(ETFs), equities tied to the theme have also suffered, despite massive inflows into funds offering exposure to Bitcoin and Ethereum (ETH).
As the familiar disclaimer goes, past performance is not indicative of future results. Shareholders of spot Bitcoin ETFs waiting for the next leg up should reconsider two funds whose expense ratios don’t appear to justify their performance, while keeping an eye on one with a notably low fee.
According to blockchain data analytics firm TRM, Bitcoin exchange-traded products (ETPs) saw nearly $10 billion in inflows in 2025. That surge followed the U.S. Securities and Exchange Commission’s approval of the first 11 spot Bitcoin ETPs on Jan. 10, 2024.
That landmark decision paved the way for funds—like the Grayscale Bitcoin Trust ETF (NYSEARCA: GBTC)—to offer indirect exposure to crypto markets by tracking the daily spot price of Bitcoin.
Investors who are uncomfortable with the DeFi landscape or simply want simpler access have flocked to these ETFs. GBTC, for example, has attracted more than $20 billion in assets under management (AUM) and posts a highly liquid average daily trading volume of just over 4 million shares.
Mirroring Bitcoin prices, the fund has stumbled lately, posting a decline of more than 29% since reaching its all-time high on Oct. 6, 2025.
GBTC charges an expense ratio of 1.5%, substantially higher than the average passively managed ETF. Worse still, despite not being actively managed, it costs more than the average actively managed ETF. For context, Vanguard charges an average of 0.05% for its ETFs.
With a smaller AUM of $2.45 billion, the ProShares Bitcoin ETF (NYSEARCA: BITO) still delivers higher average daily trading volume—nearly 60 million shares—compared with GBTC’s already strong liquidity.
The actively managed fund follows a long Bitcoin, short U.S. dollar futures strategy.
That active approach has not translated into attractive returns: over the past year, BITO has fallen nearly 50%.
Like GBTC, BITO carries an above-average expense ratio. Those fees cover everything from administrative and compliance costs to management and marketing. By comparison, the average expense ratio for actively managed ETFs is substantially lower.
According to Morningstar Direct, the average expense ratio for actively managed ETFs is 0.44%. ProShares charges 0.95% for BITO.
Current short interest of 17.42% suggests holders could face more downside risk in the near term.
The best-case scenario may be the fund offered by BlackRock (NYSE: BLK). As a spot Bitcoin ETF, the iShares Bitcoin Trust ETF (NASDAQ: IBIT) has performed similarly to GBTC and better than the actively managed BITO. Since its all-time high on Oct. 3, the fund is down about 27%.
With AUM of $68.33 billion, IBIT is the largest Bitcoin ETF on the market. Its average daily trading volume of more than 55 million shares makes it more liquid than GBTC and nearly as liquid as BITO.
Most importantly, IBIT carries an expense ratio of just 0.25%, which has made it especially attractive to institutional investors. Over the past 12 months, institutional buyers outnumbered institutional sellers 1,557 to 417, with inflows of more than $11 billion compared with outflows of about $1.55 billion. Current short interest stands at just 1.43% of the float.
The fund likely has a long-term catalyst after BlackRock announced on Jan. 21 that it partnered with insurance company Delaware Life to offer a U.S. fixed index annuity with Bitcoin exposure. That exposure will use IBIT to provide the annuity’s crypto access.
This email content is a paid advertisement from Chaikin Analytics, a third-party advertiser of MarketBeat. Why did I receive this email content?.
This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
If you have questions or concerns about your newsletter, don’t hesitate to contact our U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
Copyright 2006-2026 MarketBeat Media, LLC.
345 N Reid Place #620, Sioux Falls, SD 57103. U.S.A..
Today’s Bonus Content: Wall Street is shifting how it values AI stocks (Click to Opt-In)
RJ Hamster
UnsubscribeFebruary 11, 2026[How To] Invest Pre-IPO In SpaceX With $100! (ad)
![[How To] Invest Pre-IPO In SpaceX With $100!](https://i0.wp.com/www.marketbeat.com/images/webpush/files/thumb_20251107163807_pushbusiness-1730089640.jpg?w=1140&ssl=1)
For the first time ever, James Altucher – one of America’s top venture capitalists – is sharing how ANYONE can get a pre-IPO stake in SpaceX… with as little as $100!
[[Click Here Now To View.]]Top Dividend NewsOnsemi Is Near a Breakout—And Free Cash Flow Could Fuel ItNo Rally? Coca-Cola’s Results Still Look Like a Sweet DealThe Silver Strategy Hiding Inside IRAs (from GoldenCrest Metals)3 Stocks to Play the Summer Travel Boom as Demand Surges Again3 Insurance Stocks Hitting 52-Week Highs With More Room to RunMarriott Vacations Worldwide: Insider Buying and Capital ReturnVerizon: Your Total Return Leader for 2026 Might Be Hiding in Plain SightTrump’s Final Shocking Act Begins February 24 (from Banyan Hill Publishing)Analysts See Upside in These 3 Dividend-Boosting Financial Giants5 Stocks and ETFs to Help Shield Your Portfolio During Volatility3 ETFs Designed to Survive the Next Market Crash3 Consumer Staples Stocks Breaking Out This Month
Starlink pre-IPO opportunity with this $30 stock (ad)
A little-known stock could double as Elon Musk prepares to take Starlink public in what may be the biggest IPO in history. This company is a critical supplier to Starlink’s fast-growing satellite network. One analyst believes it’s positioned for significant upside as the IPO approaches. You can get the ticker symbol free in the first three minutes of a brief video—no credit card required.
Watch The Video To Get The Ticker Now
CompanyShare PriceAmount / PeriodYieldPrevious AmountPayout RatioPayable DateDCIDonaldson$110.79$0.30
quarterly1.16%$0.3037.4%2/27/26
FMBHFirst Mid Bancshares$43.43$0.25
quarterly2.41%$0.2526.0%2/27/26
RMDResMed$256.94$0.60
quarterly0.93%$0.6023.7%3/19/26
STBAS&T Bancorp$44.12$0.36
quarterly3.45%$0.3641.1%2/26/26
TJXTJX Companies$152.19$0.43
quarterly1.11%$0.4337.5%3/5/26
TTEKTetra Tech$42.02$0.07
quarterly0.70%$0.0719.5%2/27/26
XOMExxon Mobil$156.26$1.03
quarterly2.91%$1.0361.6%3/10/26
ZIONZions Bancorporation, N.A.$63.34$0.45
quarterly3.00%$0.4530.0%2/19/26
Please note you must purchase shares of these companies by the market close today to receive the next dividend payment.The Crash Has Already Started (Most Just Don’t See It Yet) (ad)
The same seven red flags that preceded the 1929 crash, ’70s stagflation, and the 2008 meltdown are all flashing together right now — long before the headlines catch up. Our free Bellwether Signal Report breaks down each warning in plain language and explains why more Americans are shifting from vulnerable paper assets into hard assets like gold and silver IRAs. If you want to stay ahead of the next major market turn, now is the time to act.
Claim Your Free Bellwether Signal Report Before The Next Leg Down
CompanyShare PriceAmount / PeriodYieldPrevious AmountPayout RatioPayable DateAFGAmerican Financial Group$130.20$1.50
special- – 35.0%2/25/26
AGCOAGCO$137.65$0.29
quarterly1.02%$0.2911.9%3/16/26
AITApplied Industrial Technologies$289.86$0.51
quarterly0.78%$0.4617.5%2/27/26
AMGNAmgen$367.92$2.52
quarterly3.21%$2.3866.9%3/6/26
APAMArtisan Partners Asset Management$44.13$0.57
annual1.27%- 100.7%2/27/26
ATENA10 Networks$20.50$0.06
quarterly1.37%$0.0641.4%3/2/26
AUBAtlantic Union Bankshares$41.11$0.37
quarterly3.78%$0.3772.5%2/27/26
BAHBooz Allen Hamilton$83.23$0.59
quarterly2.31%$0.5532.7%3/2/26
BHRBBurke & Herbert Financial Services$70.02$0.55
quarterly3.29%$0.5528.5%3/2/26
CCLCarnival$32.95$0.15
quarterly1.93%- – 2/27/26
CFCF Industries$97.00$0.50
quarterly2.18%$0.5024.1%2/27/26
CGCarlyle Group$54.50$0.35
quarterly2.38%$0.3578.2%2/20/26
CHDChurch & Dwight$100.56$0.31
quarterly1.28%$0.3040.7%3/2/26
CMPOCompoSecure$25.32$0.00
quarterly0.04%- – 2/27/26
CNOBConnectOne Bancorp$27.48$0.18
quarterly2.61%$0.1848.0%3/2/26
CORCencora$361.08$0.60
quarterly0.73%$0.6028.8%3/2/26
CSWCCapital Southwest$23.20$0.19
monthly11.32%$0.19128.2%2/27/26
CTASCintas$201.72$0.45
quarterly0.93%$0.4552.5%3/13/26
CUKCarnival$32.68$0.15
quarterly1.94%- 7.5%2/27/26
DOCHealthpeak Properties$17.08$0.10
monthly7.44%$0.101,220.0%2/27/26
DUKDuke Energy$124.39$1.07
quarterly3.62%$1.0767.0%3/16/26
EMREmerson Electric$163.27$0.56
quarterly1.46%$0.5654.3%3/10/26
FFord Motor$13.63$0.15
quarterly4.35%$0.1551.7%3/2/26
FHBFirst Hawaiian$26.87$0.26
quarterly3.92%$0.2647.3%2/27/26
FLOCFlowco$22.50$0.08
quarterly1.54%$0.0810.7%2/25/26
GENGen Digital$24.74$0.13
quarterly2.23%$0.1351.5%3/11/26
GRCGorman-Rupp$66.94$0.19
quarterly1.45%$0.1937.8%3/10/26
HPHelmerich & Payne$34.94$0.25
quarterly3.36%$0.25-31.3%2/27/26
HTHHilltop$39.38$0.20
quarterly2.18%$0.1827.2%2/27/26
HWKNHawkins$148.28$0.19
quarterly0.49%$0.1919.2%2/27/26
IBOCInternational Bancshares$71.95$0.732.03%- 20.7%2/27/26
IVZInvesco$26.26$0.21
quarterly3.09%$0.21-52.5%3/3/26
KGSKodiak Gas Services$51.31$0.49
quarterly4.77%$0.49245.0%2/20/26
KRKroger$68.56$0.35
quarterly2.23%$0.35129.6%3/1/26
LLYEli Lilly and Company$1,023.97$1.73
quarterly0.70%$1.5030.2%3/10/26
LNNLindsay$135.48$0.37
quarterly1.18%$0.3721.9%2/27/26
MMM3M$173.37$0.78
quarterly2.01%$0.7352.0%3/12/26
MMSMaximus$76.34$0.33
quarterly1.48%$0.3020.1%3/2/26
MSAMSA Safety Incorporporated$194.85$0.53
quarterly1.16%$0.5629.9%3/10/26
MSCIMSCI$512.96$2.05
quarterly1.33%$1.8045.9%2/27/26
MTXMinerals Technologies$73.64$0.12
quarterly0.71%$0.12-94.1%3/6/26
NXSTNexstar Media Group$237.33$1.86
quarterly3.50%$1.8646.1%2/27/26
OBKOrigin Bancorp$44.63$0.15
quarterly1.47%$0.1525.0%2/27/26
OTISOtis Worldwide$90.00$0.42
quarterly1.93%$0.4248.0%3/13/26
OTTROtter Tail$85.95$0.58
quarterly2.75%$0.5331.7%3/10/26
PFSProvident Financial Services$23.20$0.24
quarterly4.33%$0.2443.0%2/27/26
PFSIPennyMac Financial Services$90.72$0.30
quarterly0.80%$0.3012.9%2/26/26
REYNReynolds Consumer Products$23.22$0.23
quarterly4.06%$0.2363.9%2/27/26
SBRASabra Healthcare REIT$19.30$0.30
quarterly6.57%$0.30166.7%2/27/26
SBUXStarbucks$98.49$0.62
quarterly2.91%$0.62205.0%2/27/26
SCHWCharles Schwab$96.69$0.32
quarterly1.24%$0.2723.2%2/27/26
SIGISelective Insurance Group$88.13$0.43
quarterly2.05%$0.4323.0%3/2/26
SJMJ. M. Smucker$110.00$1.10
quarterly4.31%$1.10-39.2%3/2/26
STRCSarcos Technology and Robotics$99.67$0.94- $0.92- 2/28/26
SXIStandex International$265.74$0.34
quarterly0.56%$0.3430.5%2/27/26
TECHBio-Techne$63.44$0.08
quarterly0.47%$0.0862.7%2/27/26
TERTeradyne$321.23$0.12
quarterly0.21%$0.1213.8%3/13/26
TFCTruist Financial$54.80$0.52
quarterly4.09%$0.5254.6%3/2/26
TMPTompkins Financial$84.22$0.67
quarterly3.34%$0.6552.5%2/22/26
TRINTrinity Capital$15.85$0.17
monthly13.43%- 93.2%2/27/26
WAFDWaFd$33.09$0.27
quarterly3.24%$0.2737.4%2/27/26
WECWEC Energy Group$113.55$0.95
quarterly3.58%$0.8973.9%3/1/26
WSFSWSFS Financial$67.84$0.17
quarterly1.17%$0.1713.3%2/27/26
Please note you must purchase shares of these companies by the market close tomorrow to receive the next dividend payment.Do THIS 20 minutes before the markets close (ad)
My 3:40 PM Protocol (Inside)
Discover the exact framework I’m using to navigate this little-known strategy… The market isn’t waiting for you to get ready.
This is a list of companies that meet common criteria that investors use to evaluate dividend stocks. This list contains companies that have dividend yields greater than 3%, payout ratios of less than 75% (or less than 100% for REITs), five-year average annual dividend growth of at least 1.5% and a minimum market cap of $1 billion.CompanyDividend YieldAnnual PayoutPayout RatioAnnual Dividend GrowthP/E RatioMarket CapTBCGTBC Bank Group PLC6.75%GBX 711.1329.26%5.29%1.78£2.38KUKWGreencoat UK Wind PLC10.88%GBX 10.09N/A1.86%N/A£2.12KKRPKimbell Royalty9.94%$1.40N/A2.06%N/A$1.53KWUThe Western Union Company9.30%$0.9441.05%3.28%4.37$3.18KLYBLyondellBasell Industries N.V.9.45%$5.48N/A5.35%N/A$19.28KBMEB&M European Value Retail S.A.7.59%GBX 1560.73%2.73%7.36£1.83K
Thank you for subscribing to DividendStocks.com’s daily newsletter!
DividendStocks.com provides a daily email newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news. DividendStocks.com is a subsidiary of MarketBeat Media, LLC and MarketBeat.com.
If you need help with your account, please email MarketBeat’s U.S. based support team at contact@marketbeat.com.
Unsubscribe
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Sixth Floor, Sioux Falls, SD 57103-7078. United States of America..
Further Reading: [How To] Invest Pre-IPO In SpaceX With $100! (From Paradigm Press)
RJ Hamster
Find deals like clearance, just-reduced prices, items on Easy Pay & more on products like women’s jewelry, beauty, home décor & other household items.
— Read on www.qvc.com/collections/deals-daily.html
RJ Hamster
A new Congressional Budget Office outlook expects entitlement spending and the national debt to explode in the next decade.
— Read on reason.com/2026/02/11/americans-will-pay-16-trillion-in-interest-payments-on-the-national-debt-over-the-next-10-years/
RJ Hamster
Discover exclusive Kay Jewelers coupons, special offers, and jewelry deals. Shop now to save on engagement rings, necklaces, earrings, and more.
— Read on www.kay.com/
RJ Hamster
Hey, Tim Plaehn here.
Bitcoin just dipped.
Everyone’s watching the price. But they’re missing the real opportunity.
This could be the best buying moment we’ll see all year.
I’m not talking about buying Bitcoin itself…
I’ve found a simple way to turn this moment into weekly income without buying crypto, opening a Coinbase account, or trading options.
Just a $45 investment you could find in your brokerage account right now.
And you could set yourself up for your first payout as soon as next Thursday.
After that? Every Thursday. Like clockwork.
We’re talking potential payouts of $1,200 a month or more.
Click here to watch my Bitcoin Income Briefing.
I’ll show you exactly how it works and why you need to act now to catch next week’s payout.
Talk soon,
Tim Plaehn
Chief Income Strategist, Investors Alley
Additional Reading from MarketBeat Media
Submitted by Thomas Hughes. First Published: 2/5/2026.
When the price of a high-quality stock such as AbbVie (NYSE: ABBV) falls despite a report showing growth, outperformance, and better-than-expected guidance, it is often a good buying opportunity.
The only question is how far the stock may pull back. In this case, it likely won’t be far: AbbVie is well supported by market dynamics, including institutional buying and steady analyst coverage that point to accumulation and a continued uptrend.
A little-known stock could double as Elon Musk prepares to take Starlink public in what may be the biggest IPO in history. This company is a critical supplier to Starlink’s fast-growing satellite network. One analyst believes it’s positioned for significant upside as the IPO approaches. You can get the ticker symbol free in the first three minutes of a brief video—no credit card required.Watch the video to get the ticker now
The likely outcome is that this healthcare marketfinds a bottom in the $200 range and quickly rebounds to record levels.
AbbVie delivered a solid Q4 2025, underscoring the strength of its portfolio and resilience after the Humira patent transition. While Humira sales fell roughly 26% year-over-year (YOY), the drug remains a blockbuster, contributing more than $1 billion in quarterly revenue. Systemwide growth was up 10% YOY and beat expectations. Segmentally, Immunology rose 18.3% on Skyrizi and Rinvoq (each up more than 30%), while Neurology gained 17.9%. Oncology and Aesthetics were modestly down (about 1%), but growth should resume as comps ease and new launches come online.
Margins remain healthy. Revenue growth combined with operational execution drove margin expansion and faster earnings growth. Adjusted earnings rose by more than 25% versus 10% top-line growth — a gap of over 15 percentage points — and benefited from roughly a 220-basis-point margin improvement. Guidance calls for $14.37 in adjusted EPS at the low end of the range, about $0.15 above MarketBeat’s consensus, suggesting management may be conservative. The company continues to focus on product optimization, higher-margin therapies, and operational efficiency.
The analysts’ response to 2026 guidance has been constructive, highlighting double-digit growth in key products and pipeline progress. Although there were no immediate consensus revisions the morning of the release, commentary is consistent with steady coverage, a firm Moderate Buy rating, and rising price targets. Consensus forecasts a move to $250 — roughly 25% upside from key support — enough for a fresh all-time high, while some high-end targets imply up to 50% upside.
Institutional activity is also bullish: institutions own more than 70% of the stock and bought on balance throughout 2025, with nearly $2 purchased for each $1 sold. That trend has continued into early 2026, providing market support and a tailwind for the share price.
Dividends are another reason institutions and analysts favor the stock. Technically a Dividend King due to its historical relationship with Abbott Laboratories (NYSE: ABT), AbbVie pays out roughly 70% of earnings and yields more than 3% with shares near record highs.
The company is on track for its 13th dividend increase since the spin-off and has delivered about a 6% dividend compound annual growth rate, which appears sustainable. The primary investor risk is dilution; that risk is limited. Share count rises incrementally from share-based compensation, but those increases have been largely offset by share repurchases.
AbbVie’s pullback, which exceeded 5%, is understandable, but the chance of a deeper decline seems limited. Early trading shows support at critical levels, suggesting the correction may already be over. In this scenario the stock should regain traction within weeks, if not days, and could reach the $250 consensus price target before midyear — with a bull case pushing toward $300.
Thank you for subscribing to Earnings360, a morning newsletter that summarizes quarterly earnings for public companies that trade on U.S. markets.
This email content is a paid advertisement for Investors Alley, a third-party advertiser of Earnings360 and MarketBeat.
If you need help with your account, please don’t hesitate to email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC.
345 North Reid Place #620, Sioux Falls, S.D. 57103. United States of America..
Today’s Bonus Content: Wall Street is shifting how it values AI stocks (Click to Opt-In)